The ovarian cancer incidences for BRCA2 carriers were lower compared to BRCA1 carriers (incidences per 1000 person-years increased from 2 at age 60 to 11 at age 80) (Table 2). This evidence concerns the gene BRCA2 and ovarian carcinoma.